Nazneen Aziz,
Director
Nazneen Aziz is the Director of Molecular Medicine at the College of American Pathologists. In this role, Dr. Aziz is responsible for initiating and guiding genomic strategies and projects at CAP. Dr. Aziz is leading several projects at CAP to stimulate the adoption of a novel diagnostic technology, next generation sequencing, in the clinical setting. In her prior positions, Dr. Aziz was Vice President of Research and Development at Interleukin Genetics, Vice President of External Research at Point Therapeutics and Director of Translational Research at Novartis Institute of Biomedical Research. In her industry career, she has focused on personalized medicine, biomarkers, genetic tests, and development of drugs in cancer and diabetes. Prior to joining the biotechnology industry Dr. Aziz was an Assistant Professor at Harvard Medical School and Children’s Hospital in Boston where she discovered and characterized the function of a new gene involved in recessive polycystic kidney disease. Dr. Aziz received her Ph.D in molecular genetics at Massachusetts Institute of Technology where her doctoral research led to the discovery of a novel mechanism of regulation of translation of mRNAs.
|
|
|
